A new biotech has raised $245 million to test a new asthma medication that could...
The U.K. plans to create what resembles the OpenPayments database in the U.S., w...
Questions about one of AstraZeneca’s key cancer drug candidates have been doggin...
At the annual meeting of the European Society for Medical Oncology, J&J unveiled...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Roche will pay $7.1 billion for Roivant's Telavant Holdings, picking up a promis...
After nearly a decade of development, Apple Watch is now being leveraged on an e...
While promising in theory, it’s not clear dementia villages actually work.
Infertility has a new definition in the U.S. — one that could make a big differe...
Insulin prices have started to come down in the U.S. How can we ensure people ar...
Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other ...
Maternal Covid-19 vaccination offers infants immunity for up to six months, a ne...
Results presented Monday could expand the use of a Novartis therapy for metastat...
Hepatoblastoma is the most frequent liver cancer in childhood. Despite the advan...
"Massachusetts companies are taking new approaches the big guys aren’t taking ye...
"Now is the time to prove whether this is a fluke, or a reflection of true benef...
